It may be worthwhile to test for and treat vitamin D deficiency in latent infection, but not in active TB
In this issue of the Journal, MacLachlan and Cowie advocate increased testing of vitamin D (serum 25-hydroxyvitamin D [25-OHD]) for people with risk factors for vitamin D deficiency and tuberculosis (TB).1 This pertinent suggestion is based on the assumption that vitamin D deficiency is a risk factor for progression from latent to active TB, and that correction of deficiency could reduce this risk (the demonstration by MacLachlan and colleagues2 of TB seasonality in Australia is consistent with this hypothesis). The proposal presents a timely opportunity to scrutinise evidence of an association between vitamin D deficiency and TB, temper the high hopes that vitamin D might be an important adjunctive treatment for active TB, and remind clinicians about problems with testing and interpreting 25-OHD levels.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. MacLachlan JH, Cowie BC. Epidemiology of tuberculosis and levels of vitamin D in Australia: person, place and time. Med J Aust 2013; 199: 655-656.
- 2. MacLachlan JH, Lavender CJ, Cowie BC. Effect of latitude on seasonality of tuberculosis, Australia, 2002-2011. Emerg Infect Dis 2012; 18: 1879-1881.
- 3. Ralph AP, Lucas RM, Norval M. Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis. Lancet Infect Dis 2013; 13: 77-88.
- 4. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773.
- 5. Ralph AP, Kelly PM, Anstey NM. L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis. Trends Microbiol 2008; 16: 336-344.
- 6. Selvaraj P, Prabhu Anand S, Harishankar M, Algarasu K. Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin D receptor and cathelicidin in pulmonary tuberculosis. J Clin Immunol 2009; 29: 470-478.
- 7. Conesa-Botella A, Meintjes G, Coussens AK, et al. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Clin Infect Dis 2012; 55: 1004-1011.
- 8. Ralph AP, Waramori G, Pontororing GJ, et al. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLOS One 2013; 8: e70032.
- 9. Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179: 843-850.
- 10. Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242-250.
- 11. Lavender TW, Martineau AR, Quinton R, Schwab U. Severe hypercalcaemia following vitamin D replacement for tuberculosis-associated hypovitaminosis D. Int J Tuberc Lung Dis 2012; 16: 140.
- 12. Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci U S A 2012; 109: 15449-15454.
- 13. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006; 38: 3-5.
- 14. Salahuddin N, Ali F, Hasan Z, et al. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis. BMC Infect Dis 2013; 13: 22.
- 15. Talat N, Perry S, Parsonnet J, et al. Vitamin D deficiency and tuberculosis progression. Emerg Infect Dis 2010; 16: 853-855.
- 16. Vieth R. Vitamin D nutrient to treat TB begs the prevention question. Lancet 2011; 377: 189-190.
- 17. Royal College of Pathologists of Australasia. Use and interpretation of vitamin D testing. Position statement. May 2013. http://www.aims.org.au/documents/item/347 (accessed Sep 2013).
- 18. Perterlik M. Vitamin D insufficiency and chronic diseases: hype and reality. Food Funct 2012; 3: 784-794.
- 19. Michaëlsson K, Baron JA, Snellman G, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010; 92: 841-848.
- 20. Dror Y, Giveon SM, Hoshen M, et al. Vitamin D levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J Clin Endocrinol Metab 2013; 98: 2160-2167.
- 21. Nielsen NO, Skifte T, Andersson M, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr 2010; 104: 1487-1491.
- 22. Cannell J. Why should you keep your vitamin D level around 50 ng/ml? Vitamin D Council Newsletter 2011, 23 Sep.
Anna Ralph is supported by National Health and Medical Research Council Grant 605806 and Fellowship 1016567. Robyn Lucas is supported by a National Health and Medical Research Council Career Development Fellowship.
No relevant disclosures.